Chemoinformaics analysis of nonyl-nonylphenol
| Molecular Weight | 220.356 | nRot | 8 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 6 |
| Exact Molecular Weight | 220.183 | nRing | 1 |
| Solubility: LogS | -5.002 | nHRing | 0 |
| Solubility: LogP | 5.906 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.63 |
| Synth | 1.666 |
| Natural Product Likeliness | 0.456 |
| NR-PPAR-gamma | 0.906 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.025 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.614 |
| MDCK | 0.0000128 |
| BBB | 0.698 |
| PPB | 0.976753 |
| VDSS | 2.693 |
| FU | 0.0112802 |
| CYP1A2-inh | 0.934 |
| CYP1A2-sub | 0.286 |
| CYP2c19-inh | 0.777 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.362 |
| CYP2c9-sub | 0.943 |
| CYP2d6-inh | 0.633 |
| CYP2d6-sub | 0.588 |
| CYP3a4-inh | 0.32 |
| CYP3a4-sub | 0.141 |
| CL | 7.175 |
| T12 | 0.466 |
| hERG | 0.058 |
| Ames | 0.056 |
| ROA | 0.087 |
| SkinSen | 0.936 |
| Carcinogencity | 0.072 |
| EI | 0.987 |
| Respiratory | 0.631 |
| NR-Aromatase | 0.69 |
| Antiviral | Yes |
| Prediction | 0.80484 |